TubeMogul Program to Provide Automatic Refunds for Non-Human Traffic
Feb 29, 2016 13:00 pm UTC| Business
EMERYVILLE, Calif., Feb. 29, 2016 -- Today, TubeMogul (NASDAQ:TUBE), an enterprise software company for brand advertising, announced the launch of its Non-Human Traffic Credit Program. Available to platform clients that...
Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 29, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
TOMI™ to Present at the 28th Annual ROTH Conference
Feb 29, 2016 13:00 pm UTC| Business
BEVERLY HILLS, Calif., Feb. 29, 2016 -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, announced it will present at the 28th Annual ROTH...
Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare Conference
Feb 29, 2016 13:00 pm UTC| Business
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 29, 2016 -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company focused on developing and commercializing...
Feb 29, 2016 12:46 pm UTC| Business
Cleveland, Ohio, Feb. 29, 2016 -- Following a concerted, year-long collaboration between The Center for Health Affairs, University Hospitals, and Cypress Research Group, University Hospitals has released their 2015...
UPDATE -- LKQ Corporation Announces Agreement to Acquire Pittsburgh Glass Works
Feb 29, 2016 12:38 pm UTC| Business
CHICAGO, Feb. 29, 2016 -- LKQ Corporation (Nasdaq:LKQ) announced that it has signed a definitive agreement to acquire Pittsburgh Glass Works LLC (“PGW”) from private equity firm Kohlberg Company LLC (“Kohlberg”) and...
Summit Therapeutics Supports Ninth Annual Rare Disease Day
Feb 29, 2016 12:35 pm UTC| Business
OXFORD, UK, Feb. 29, 2016 -- Summit Therapeutics plc (NASDAQ:SMMT) (LSE:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and Clostridium difficile infection,...